Elutia (ELUT) director granted 171,916 options at $0.88
Elutia Inc. (ELUT) reported a director stock option grant covering 171,916 shares at an exercise price of $0.88 on October 9, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Elutia Inc. (ELUT) reported a director stock option grant covering 171,916 shares at an exercise price of $0.88 on October 9, 2025. The option vests in three equal annual installments and becomes fully exercisable on October 9, 2028, with an expiration date of October 9, 2035. After the grant, 171,916 derivative securities were beneficially owned, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 171,916 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option vests annually in three equal installments of one-third each, on each of the first three anniversaries of the grant date, such that the option shall be fully vested and exercisable on October 9, 2028.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ELUT disclose in this Form 4?
What is the vesting schedule for the ELUT option grant?
When do the ELUT options expire?
How many derivative securities were held after the transaction?
What is the relationship of the reporting person to ELUT?
Was this filing made by one person or a group?
AI-generated analysis. How Rhea-AI works. Not financial advice.